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Aims Atherosclerosis develops near branches and bends of arteries that are exposed to disturbed blood flow which
exerts low wall shear stress (WSS). These mechanical conditions alter endothelial cells (EC) by priming them for in-
flammation and by inducing turnover. Homeobox (Hox) genes are developmental genes involved in the patterning
of embryos along their anterior–posterior and proximal–distal axes. Here we identified Hox genes that are regu-
lated by WSS and investigated their functions in adult arteries.
....................................................................................................................................................................................................
Methods
and results
EC were isolated from inner (low WSS) and outer (high WSS) regions of the porcine aorta and the expression of
Hox genes was analysed by quantitative real-time PCR. Several Hox genes (HoxA10, HoxB4, HoxB7, HoxB9,
HoxD8, HoxD9) were significantly enriched at the low WSS compared to the high WSS region. Similarly, studies
of cultured human umbilical vein EC (HUVEC) or porcine aortic EC revealed that the expression of multiple Hox
genes (HoxA10, HoxB9, HoxD8, HoxD9) was enhanced under low (4 dyn/cm2) compared to high (13 dyn/cm2)
WSS conditions. Gene silencing studies identified Hox genes (HoxB9, HoxD8, HoxD9) that are positive regulators
of inflammatory molecule expression in EC exposed to low WSS, and others (HoxB9, HoxB7, HoxB4) that regu-
lated EC turnover. We subsequently focused on HoxB9 because it was strongly up-regulated by low WSS and,
uniquely, was a driver of both inflammation and proliferation. At a mechanistic level, we demonstrate using cultured
EC and murine models that bone morphogenic protein 4 (BMP4) is an upstream regulator of HoxB9 which elicits
inflammation via induction of numerous inflammatory mediators including TNF and downstream NF-jB activation.
Moreover, the BMP4-HoxB9-TNF pathway was potentiated by hypercholesterolaemic conditions.
....................................................................................................................................................................................................
Conclusions Low WSS induces multiple Hox genes that control the activation state and turnover of EC. Notably, low WSS acti-
vates a BMP4-HoxB9-TNF signalling pathway to initiate focal arterial inflammation, thereby demonstrating integra-
tion of the BMP and Hox systems in vascular pathophysiology.
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Graphical Abstract
1. Introduction
Although associated with risk factors that act systemically (e.g. hypercho-
lesterolaemia, smoking, age), atherosclerosis develops preferentially
near branches and bends of arteries.
1,2 Disturbed blood flow at these sites generates low wall shear stress
(WSS)3,4 which promotes atherogenesis by inducing vascular inflamma-
tion4–6 and endothelial cell (EC) turnover7,8 coupled to enhanced per-
meability to cholesterol-containing lipoproteins.9 Low WSS also
correlated with plaque burden in patients with coronary artery dis-
ease,10,11 and in animal models where low WSS promoted the develop-
ment of inflamed lesions with features of vulnerability.12,13 By contrast,
regions of arteries that are exposed to uniform flow generating high
time-averaged WSS are protected from inflammation and atherosclero-
sis. Focal atherosclerosis is driven by bone morphogenic protein 4
(BMP4) which is up-regulated by low oscillatory WSS and down-regu-
lated by high WSS in cultured EC,14 and correspondingly is enriched at
sites of low WSS in the murine aorta and in EC overlying human coro-
nary artery plaques.14,15 At a functional level, BMP4 induces EC expres-
sion of VCAM-1 and ICAM-114–16 which elicit vascular inflammation by
capturing circulating leucocytes from the bloodstream to the vessel wall.
Here we investigated the mechanisms that couple BMP4 to EC activation
and inflammation and found that it signals via a member of the
Homeobox (Hox) family.
Hox transcription factors were discovered in Drosophila mela-
nogaster17 and shown to regulate multiple developmental processes in
both invertebrates and vertebrates.18 The human genome contains 39
HOX genes that localize to four clusters in the genome (called HOX A,
B, C, and D). They are expressed at distinct regions of the embryo and
act as master regulators of segmental identity and body patterning by ac-
tivating transcriptional programmes that control cell fate decisions.19
Notably, the expression of several Hox gene varies according to the
anatomy of the vascular tree.20–26 For example, HoxA1 expression is en-
hanced in the aortic arch which is relatively prone to atherosclerosis
compared to the thoracic aorta which is atheroresistant,22 whereas
HoxA4 exhibits the opposite pattern.23 Although some Hox genes ex-
hibit a distinct pattern of expression in arteries, their potential function
in arterial EC and contribution to atherosusceptibility has not been
studied.
Here we identified several Hox genes that were enriched at a low
WSS region of the aorta. Gene silencing studies revealed that Hox genes
are necessary for inflammation, EC proliferation, and EC apoptosis in EC
exposed to low WSS. Detailed mechanistic studies revealed a BMP4-
HoxB9 pathway that primed EC exposed to low WSS for inflammation
by inducing the expression of multiple inflammatory mediators, recep-
tors, and signalling molecules.
2. Methods
2.1 Materials
BMP4 and anti-TNF blocking antibodies were obtained commercially
(Supplementary material online, Table S1). DMH1 and LDN193189
were obtained from Sigma.
Low oscillatory WSS
BMP4
HoxB9
TNF
NFkB
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2.2 Isolation of EC, culture, and exposure
toWSS
Pig aortas from 4 to 6months old animals (weight approximately 80 kg)
were obtained immediately after slaughter from a local abattoir. They
were cut longitudinally along the outer curvature to expose the lumen.
Porcine aortic EC (PAEC) exposed to high (outer curvature) or low (in-
ner curvature) WSS were harvested using collagenase (1mg/mL for
10min at room temperature) prior to gentle scraping for analysis by
quantitative real-time PCR (qRT-PCR). For cell culture experiments,
PAECwere isolated using collagenase digestion and cultured on 1% gela-
tin using M199 growth medium supplemented with foetal bovine serum
(20%), L-glutamine (4mmol/L), EC growth supplement (30mg/mL), peni-
cillin (100U/mL), streptomycin (100mg/mL), and heparin (10 IU/mL).
Human umbilical vein EC (HUVEC) were purchased from PromoCell
and cultured according to the manufacturer’s recommendations. EC at
passage 3–5 were cultured until confluent in 6-well plates and exposed
to flow using an orbital shaking platform (PSU-10i; Grant Instruments)
housed inside a cell culture incubator. The radius of orbit of the orbital
shaker was 10mm and the rotation rate was set to 210 rpm. This motion
caused swirling of the culture medium over the cell surface generating
low WSS (approximately 5 dynes/cm2) with varied directionality at the
centre and high (approximately 11 dynes/cm2) WSS with uniform direc-
tion at the periphery. Alternatively, HUVEC were cultured on Ibidi
gelatin-coated m-Slides (Ibidi GmbH) until they reached confluency.
Flowing medium was then applied using the Ibidi pump system to gener-
ate low (4dyn/cm2), low oscillatory (±4 dyn/cm2, 0.5Hz), or high
(13 dyn/cm2) WSS. The slides and pump apparatus were enclosed in a
cell culture incubator warmed to 37C.
2.3 Mouse lines
HoxB9-/-mice (C57BL/6) obtained from Prof. Mario Capecchi,27 ApoE-/-
(apolipoprotein-E null) mice and wildtype C57BL/6 controls were
housed under specific-pathogen free conditions. Some ApoE-/- mice
were exposed to a high fat diet containing 21% (wt/wt) fat, 0.15% (wt/
wt) cholesterol, and 0.296% (wt/wt) sodium for 6weeks. Animal care
and experimental procedures were carried out under licenses issued by
the UK HomeOffice and local ethical committee approval was obtained.
All animal procedures conformed to the guidelines from Directive 2010/
63/EU of the European Parliament on the protection of animals used for
scientific purposes. Mice between 2 and 3months of age were used for
experimentation. Experiments were carried out using female mice be-
cause vascular physiology varies between sexes in mice.
2.4 En face staining of murine endothelium
The expression levels of specific proteins were assessed in EC at regions
of the inner curvature (susceptible site) and outer curvature (protected
site) of murine aortae by en face staining. Animals were killed by intraper-
itoneal injection of pentobarbital (40mg) and aortae were perfused in
situ with PBS (at a pressure of approximately 100mm Hg) and then
perfusion-fixed with 4% paraformaldehyde prior to harvesting. Fixed
aortae were tested by immunostaining using specific primary antibodies
(Supplementary material online, Table S1) and Alexafluor568-conjugated
or Alexafluor488-conjugated secondary antibodies. EC were identified
by co-staining using anti-CD31 or anti-CDH5 antibodies. Nuclei were
identified using a DNA-binding probe with far-red emission (To-Pro-3).
Stained vessels were mounted prior to visualization of endothelial surfa-
ces en face using confocal laser-scanning microscopy (Zeiss LSM510
NLO inverted microscope). Isotype-matched monoclonal antibodies
raised against irrelevant antigens or pre-immune rabbit sera were used
as experimental controls for specific staining. The expression of particu-
lar proteins at each site was assessed by quantification of fluorescence in-
tensity for multiple cells (at least 50 per site) using Image J (1.49p) and
calculation of mean fluorescence intensities with standard error of the
mean (SEM).
2.5 Gene silencing
Cell cultures were transfected with siRNA sequences that are known to
silence HoxA10, HoxB4, HoxB7, HoxB9, HoxD8, HoxD9, or BMP4
(Dharmacon; Supplementary material online, Table S2) using the
Lipofectamine
VR
RNAiMAX transfection system (13778-150, Invitrogen)
following the manufacturer’s instructions. Non-targeting scrambled
sequences were used as a control (D-001810-01-50 ON-TARGETplus
Non-targeting siRNA#1, Dharmacon).
2.6 Comparative real-time PCR
RNA was extracted using the RNeasy Mini Kit (74104, Qiagen) and re-
verse transcribed into cDNA using the iScript cDNA synthesis kit
(1708891, Bio-Rad). The levels of human or porcine transcripts were
assessed using qRT-PCR using gene-specific primers (Supplementary ma-
terial online, Table S3). Reactions were prepared using SsoAdvanced uni-
versal SYBR
VR
Green supermix (172-5271, Bio-Rad) and were run in
triplicate following the manufacturer’s instructions. Relative gene expres-
sion was calculated by comparing the number of thermal cycles that were
necessary to generate threshold amounts of product. Fold changes were
calculated using the DDCt method. Data were pooled from at least three
independent experiments and mean values were calculated with SEM.
2.7 Western blotting
Total cell lysates were isolated using lysis buffer (containing 2% SDS,
10% glycerol, and 5% b-mercaptoethanol). Western blotting was carried
out using specific primary antibodies (Supplementary material online,
Table S1) and horse radish peroxidase-conjugated secondary antibodies
obtained commercially from Dako and chemiluminescent detection was
carried out using ECL Prime
VR
(GE Healthcare). Membranes were imaged
using the Gel Doc XRþ system (Bio-Rad).
2.8 Assay of NF-jB DNA binding
Binding of RelA and p50 NF-jB subunits to DNA was quantified using
the TransAm system according to the manufacturer’s instructions
(Active Motif).
2.9 Immunofluorescent staining of cultured
EC
Immunofluorescent staining of cultured EC was carried out using specific
antibodies followed by widefield fluorescence microscopy
(LeicaDMI4000B). HUVEC were fixed with paraformaldehyde (4%) and
permeabilized with Triton X-100 (0.1%). Following blocking with goat
or donkey serum for 30min monolayers were incubated for 16h with
primary antibodies against proliferating cell nuclear antigen (PCNA)
(proliferation marker), active caspase-3 (apoptosis marker), CDH5 (en-
dothelial marker), RelA, HoxB9, and AlexaFluor488- or Alexafluor568-
conjugated secondary antibodies. Nuclei were identified using the DNA-
binding probe DAPI (Sigma). Image analysis was performed using Image J
software (1.49p) to calculate the frequency of positive cells. Isotype con-
trols or omission of the primary antibody was used to control for non-
specific staining.
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2.10 Statistical analysis
Differences between samples were analysed using an unpaired or paired
Student’s t-test or ANOVA (*P<0.05, **P<0.01, ***P<0.001).
3. Results
3.1 LowWSS induces multiple Hox genes
in atheroprone endothelium
A recent microarray study from our group suggested that several Hox
genes were differentially expressed at high and low WSS regions of the
aorta. qPCR studies of an independent cohort of pigs demonstrated that
EC isolated from the low shear stress region (inner curvature) had enriched
expression of HoxA10, HoxB4, HoxB7, HoxB9, HoxD8, and HoxD9
(Figure 1A), thus confirming anatomical variation in Hox gene expression.
Given their enrichment at atheroprone sites, we hypothesized that
Hox genes are regulated byWSS. This was tested by exposing PAEC or
HUVEC to high (12 dynes/cm2) or low (4 dynes/cm2) WSS using either
orbital or parallel plate flow systems. To validate the approach, we con-
firmed using each of these systems that CCL2 was enriched in cells ex-
posed to low WSS whereas protective mRNAs (KLF2 or eNOS) were
enhanced by high WSS (Supplementary material online, Figure S1). qRT-
PCR revealed that mRNA levels of HoxA10, HoxB9, HoxD8, and
HoxD9 were significantly elevated in PAEC exposed to low WSS com-
pared to cells exposed to high WSS using an orbital shaker system, with
HoxB9 and HoxD9 exhibiting the greatest enrichment (Figure 1B). A
similar pattern of expression was observed in HUVEC exposed to low
vs. high WSS using either an orbital (Figure 1C) or parallel plate system
(Supplementary material online, Figure S2). We concluded that lowWSS
induces several Hox genes in atheroprone endothelium and that HoxB9
and HoxD9 were prominently expressed.
3.2 Hox genes drive inflammation and
endothelial turnover in low shear
conditions
We next studied the potential role ofWSS-regulated Hox genes in inflam-
mation, proliferation, and apoptosis. Each Hox gene was targeted in EC
exposed toWSS using siRNA and the efficiency of gene silencing wasmea-
sured by qRT-PCR (Supplementary material online, Figure S3). We used
VCAM-1 expression in cultured HUVEC as a marker of inflammation.
Silencing of HoxB9, HoxD8, and HoxD9 significantly reduced VCAM-1
mRNA levels under low WSS whereas HoxA10, HoxB4, and HoxB7 si-
lencing had no effect (Figure 2A). To validate these observations, the regula-
tion of VCAM-1 by HoxB9, HoxD8, and HoxD9 was confirmed using a
different siRNA (Supplementary material online, Figure S4). Moreover,
each of these Hox genes was also shown to positively regulate the expres-
sion of two other inflammatory genes, E-selectin and CCL2 (Figure 2B). It
was concluded that HoxB9, HoxD8, and HoxD9 enhance inflammatory
activation of EC exposed to pro-atherogenic disturbed flow.
Proliferation and apoptosis, which were quantified by immunofluores-
cent staining of PCNA or active caspase-3, were enhanced in HUVEC
exposed to low compared to highWSS (Supplementary material online,
Figure S5). Proliferation rates were significantly reduced by silencing of
HoxB4, HoxB7, and HoxB9 but unaltered by silencing of HoxA10,
HoxD8, and HoxD9 (Figure 2C). Silencing of HoxB4 reduced apoptosis
(Figure 2D).We conclude that HoxB4, HoxB7, and HoxB9 promote pro-
liferation in EC exposed to low WSS whereas HoxB4 is pro-apoptotic.
These studies show that Hox genes have non-redundant pathophysio-
logical roles in vascular endothelium with several promoting inflamma-
tion and others regulating proliferation and apoptosis (Figure 6). HoxB9
is of considerable interest because it is highly abundant at the athero-
prone region of the aorta and it drives two processes that promote ath-
erosclerosis; inflammation and proliferation.
Figure 1 Low WSS induces multiple Hox genes. (A) Porcine aortae
were cut along the outer curvature to expose the lumen and ECs were
isolated from low and high WSS regions. Data were pooled from five
pigs. (B) PAECs (HOXA10, HOXB4, HOXB7, HOXB9, HOXD8,
N=9; HOXD9, N=4) or (C) HUVECs (HOXA10, HOXB4, N=5;
HOXB7, HOXB9, HOXD8, N=6; HOXD9, N=4) were cultured in
6-well plates and exposed to orbital shaking to generate WSS. After
72 h, cells were isolated from the centre (low WSS) or the periphery
(highWSS) of the well. (A, B, and C) Hox genemRNA levels were quan-
tified by qRT-PCR using gene-specific primers. Mean expression levels
in low WSS conditions were normalized to levels in high WSS (dotted
line) and are shownwith standard deviations. *P<0.05, **P<0.01 using
an unpaired two-tailed t-test.
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Figure 2 Hox genes are required for endothelial activation, proliferation, and apoptosis. HUVECs were transfected with siRNA targeting specific Hox
genes or with scrambled control sequences. Cells were then exposed for 72h to low (centre) or high (periphery)WSS using the orbital system. mRNA lev-
els of VCAM-1 (A) or E-selectin and CCL2 (B) were quantified by qRT-PCR. Mean expression levels in low WSS conditions were normalized to levels in
highWSS (dotted line) and are shown with standard deviations. Proliferation and apoptosis were quantified by immunofluorescent staining using antibodies
that detect PCNA (C; green) or cleaved caspase-3 (D; green) and counterstaining nuclei using DAPI (blue). Mean frequencies of PCNA-positive or apoptotic
cells in lowWSS conditions were normalized to levels in highWSS (dotted line) and are shown with standard deviations. Bar = 75lm. *P<0.05, **P<0.01,
***P<0.001 using an unpaired two-tailed t-test.
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Figure 3 HoxB9 promotes inflammatory activation in response to low WSS. (A–C) HUVECs were transfected with siRNA targeting HoxB9 or with
scrambled control sequences. Cells were then exposed for 72 h to low (centre)WSS using the orbital system. (A) Nuclear expression of RelA was assessed
by immunostaining (in red) in combination with stainings for nuclei (DAPI-blue) and endothelial marker CDH5 (green). Bar = 10lm. (B) The activity of RelA
and p50 NF-jB subunits was assessed by DNA-binding ELISA. Mean optical density (OD) 450 nm values± SEM are shown. (C) The expression levels of
VCAM-1 and IjBa were assessed by Western blotting using specific antibodies and anti-Calnexin was used to control for total protein levels. (D) The ex-
pression of HoxB9 was quantified at the inner curvature (low WSS) and outer curvature (high WSS) of the murine aortic arch by en face staining (green).
N=5. Bar = 10lm. (E) Wild-type or HoxB9-/- mice were studied (N=7/group). The expression of E-selectin was quantified at the inner curvature of the
murine aortic arch by en face staining. Bar = 10lm. (D and E) EC were identified using anti-CD31 antibodies (red) and nuclei were co-stained using
TOPRO3 (purple). Differences betweenmeans were analysed using an unpaired (A, B, C, and E) or paired (D) t-test. *P<0.05, **P<0.01, ***P<0.001.
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3.3 HoxB9 drives inflammation at
atheroprone areas
To define the mechanism linking HOXB9 to inflammation we studied its
potential effects on NF-jB transcription factors which induce inflamma-
tion by activating inflammatory genes. The most abundant form of NF-
jB in EC is the RelA/p50 heterodimer which is enriched at atherosus-
ceptible regions of arteries.28,29 Focusing on this form, we observed that
silencing of HoxB9 reduced nuclear localization (Figure 3A) and DNA
binding (Figure 3B) of NF-jB and simultaneously reduced the expression
of VCAM-1 and E-Selectin (Figure 3C). It was therefore concluded that
HoxB9 is a positive regulator of NF-jB. Although KLF2 can influence
NF-jB,30we observed that KLF2 expression was not altered by silencing
of HoxB9 (Supplementary material online, Figure S6A). Silencing of
HoxB9 enhanced the expression of the NF-jB inhibitor IjBa (Figure 3C),
suggesting that HoxB9 activates NF-jB by reducing IjBa expression.
We validated the role of HoxB9 in inflammation by studying the ex-
pression and function of HoxB9 in EC exposed to low WSS (inner cur-
vature) or highWSS (outer curvature) of the murine aortic arch. En face
staining using anti-HoxB9 antibodies demonstrated that HoxB9 was sig-
nificantly enriched at the lowWSS region (Figure 3D), which is consistent
with our in vitro observations. To study the function of HoxB9, we ana-
lysed the effects of genetic deletion of HoxB9 on endothelial activation.
En face staining revealed that the expression of E-selectin at the low
WSS region was significantly reduced in HOXB9-/- compared to wild-
type mice (Figure 3E), indicating that HOXB9 enhances inflammation at
lowWSS regions of arteries.
3.4 HoxB9 potentiates the TNF pathway
Themechanism linking HoxB9 to the NF-jB signalling pathwaywas stud-
ied in an unbiased way using a qRT-PCR array. Silencing of HoxB9 signifi-
cantly reduced the expression of multiple inflammatory receptors and
signalling molecules including TNF receptor superfamily members, TLRs,
TRAFs, and IRAKs suggesting that it primes EC for enhanced responses
to multiple inflammatory mediators (Figure 4A and Supplementary mate-
rial online, Figure S7). Interestingly, HoxB9 negatively regulates the ex-
pression of IL-1b which can have both protective and pathogenic effects
in atherosclerosis.31 We subsequently focused on the TNF pathway be-
cause HoxB9 positively regulated both TNF and its receptor TNFR1 and
because this pathway is a key driver of NF-jB. Independent experiments
confirmed that silencing of HoxB9 reduced the expression of TNF and
TNFR1 in vitro (Figure 4B and C) and reduced TNFR1 at atheroprone
areas (Figure 4D). Moreover, we concluded that endogenous TNF is in-
volved in the inflammatory response to low WSS because inhibition of
TNF using blocking antibodies significantly reduced NF-jB activity
(Figure 4E). In conclusion, HoxB9 induced the expression of multiple in-
flammatory molecules including components of the TNF pathway which
drives inflammation in response to lowWSS.
3.5 BMP4 regulates HoxB9 expression in
response to disturbed flow
Since BMP4 is known to be enriched at lowWSS regions of arteries15 and
induces HoxB9 during embryogenesis32we hypothesized that BMP4 regu-
lates HoxB9 at atheroprone sites. Consistent with this, BMP4 is enriched in
HUVEC exposed to low WSS compared to high WSS (Figure 5A).
Similarly, en face staining revealed enhanced expression of BMP4 at the in-
ner (lowWSS) compared to the outer (highWSS) curvature of themurine
aortic arch (Figure 5B). These data recapitulate previous observations that
EC exposed to disturbed flow are primed for enhanced BMP signalling.15,16
The potential link between BMPs and HoxB9 was studied in HUVECs
using DMH1 (ALK2 inhibitor) or LDN193189 (ALK1, ALK2, ALK3, ALK6
inhibitor). Both compounds reduced the expression of the BMP target
gene ID1 thereby confirming their efficacy (Figure 5C and D). Inhibition of
BMP signalling significantly reduced the expression of HoxB9 mRNA
(Figure 5C and D) andHoxB9 protein (Figure 5E and F), demonstrating that
BMP signalling positively regulates HoxB9 in response to low WSS. We
next focused on the potential role of BMP4 in HoxB9 up-regulation. The
addition of exogenous BMP4 to cultured HUVEC induced HoxB9 in a
dose-dependent manner (Figure 5G), whereas silencing of BMP4 reduced
HoxB9 expression in HUVEC exposed to lowWSS (Figure 5H). We con-
cluded that low WSS induces HoxB9 via BMP4 in vascular endothelium.
Interestingly, silencing of HoxB9 significantly enhanced the expression of
BMP4 indicating that HoxB9 is a negative regulator of BMP4
(Supplementary material online, Figure S8). Overall, these data demon-
strate that BMP4 induces HoxB9 in vascular endothelium, and that a nega-
tive feedback loop exists to limit BMP4 expression.
We next investigated whether the BMP4-HoxB9 pathway promotes
inflammation by quantifying inflammatory gene expression in HUVEC
that were treated with BMP4 in the presence of absence of HoxB9. It was
observed that BMP4 induced TNF and TNFR1, and also induced VCAM-
1 and E-selectin, and that these responses were abolished by silencing of
HoxB9 (Figure 5I). By contrast, BMP4 did not alter the expression of KLF2
(Supplementary material online, Figure S6B). Therefore, it was concluded
that BMP4 promotes inflammatory gene expression via HoxB9.
Finally, we investigated whether the BMP4-HoxB9-TNF axis is poten-
tially involved in atherogenesis by determining the effects of hypercholes-
terolaemia on the expression of components of this pathway.
Hypercholesterolaemia was induced in ApoE-/- mice by exposure to a
high fat diet for 6weeks. En face staining of the aorta revealed that the ex-
pression of BMP4, HoxB9, and TNFR1 at the inner curvature (lowWSS)
was enhanced in hypercholesterolaemic mice compared to controls
(Supplementary material online, Figure S9), indicating that the BMP4-
HoxB9-TNF pathway is potentiated by pro-atherogenic conditions.
In conclusion, low WSS and hypercholesterolaemia induce a BMP4-
HoxB9-TNF-NF-jB pathway that drives inflammation during early
atherogenesis.
4. Discussion
4.1 A Hox gene code regulates EC fate at
disease-prone sites
Hox genes are critical developmental genes involved in the patterning of
the embryos along their anterior–posterior and proximal–distal axis.
However, Hox genes are also expressed in adult, notably in the vascula-
ture where several of them are differentially expressed at atheroprone
and atheroprotected regions of the arterial tree.20–26,33 For example,
HoxA9, HoxA10, and HoxD3 were expressed at higher levels in EC iso-
lated from iliac arteries that are relatively protected from atherosclerosis
compared to coronary arteries that are atherosusceptible.20,21
Moreover, HoxA1 endothelial expression is enhanced in the aortic arch
(atherosusceptible) compared to the thoracic aorta (atheroprotected)22
whereas HoxA4 displayed the opposite pattern.23 Collectively, these
observations suggest that the spatial organization of HOX gene expres-
sion in ECmay influence focal atherosusceptibility.
An elegant study from Trigueros-Motos et al.26 revealed that the ex-
pression of Hox genes in vascular smooth muscle cells (VSMCs) also varies
according to anatomy. Intriguingly, the expression of HoxA10, HoxB7,
HoxB9 promotes arterial inflammation 7
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Figure 4 HoxB9 is required for inflammation at atheroprone regions of the aorta. (A–C) HUVECs were transfected with siRNA targeting HoxB9 or with
scrambled control sequences. Cells were then exposed for 72 h to lowWSS using the orbital system. (A) The expression levels of multiple transcripts that
regulate inflammation were quantified by qRT-PCR array. (B) The expression levels of TNF were assessed byWestern blotting using specific antibodies and
anti-Calnexin was used to control for total protein levels. (C) TNFR1mRNA levels were quantified by qRT-PCR using gene-specific primers.N=3. Mean ex-
pression levels are shown with standard deviations. (D) Wild-type or HoxB9-/- mice were studied (N=6/group). The expression of TNFR1 (green) was
quantified at the inner curvature of themurine aortic arch by en face staining. ECwere identified using anti-CD31 antibodies (red) and nuclei were co-stained
using TOPRO3 (purple). (E) HUVECs were treated with TNF blocking antibodies and then exposed for 72h to low (centre) or high (periphery)WSS using
the orbital system. The activity of RelA and p50 NF-jB subunits was assessed by DNA-binding ELISA. Mean optical density (OD) 450 nm values± SEM are
shown.N=3 independent experiments. Differences between means were analysed using an unpaired t-test. *P<0.05, **P<0.01.
8 C. Souilhol et al.
D
o
w
n
lo
a
d
e
d
 fro
m
 h
ttp
s
://a
c
a
d
e
m
ic
.o
u
p
.c
o
m
/c
a
rd
io
v
a
s
c
re
s
/a
d
v
a
n
c
e
-a
rtic
le
-a
b
s
tra
c
t/d
o
i/1
0
.1
0
9
3
/c
v
r/c
v
z
2
3
5
/5
5
5
6
2
9
2
 b
y
 U
n
iv
e
rs
ity
 o
f S
h
e
ffie
ld
 u
s
e
r o
n
 2
2
 O
c
to
b
e
r 2
0
1
9
Figure 5 BMP4 induces HoxB9 in response to low shear stress. (A) HUVEC were cultured in 6-well plates and exposed to orbital shaking to generate
WSS. After 72h, cells were isolated from the centre (lowWSS) or the periphery (high WSS) of the well. BMP4 mRNA levels were quantified by qRT-PCR
using gene-specific primers. N=3 experiments. (B) The expression of BMP4 was quantified at the inner curvature (low WSS) and outer curvature (high
WSS) of the murine aortic arch by en face staining (red). EC were identified using anti-CD31 antibodies (green) and nuclei were co-stained using TOPRO3
(blue). N=3. (C–F) HUVEC were treated with DMH1 or LDN and then exposed to lowWSS for 72h. Bar= 10lm. (C and D) mRNA levels of HoxB9 or
ID1 were quantified by qRT-PCR using gene-specific primers. N=4–7 experiments. (E) The expression levels of HoxB9 were assessed byWestern blotting
using specific antibodies and anti-Calnexin was used to control for total protein levels. N=4 experiments. (F) HoxB9 expression was assessed by immuno-
fluorescent staining (red). EC were identified using anti-CDH5 antibodies (green) and nuclei were co-stained using DAPI (blue). N=4. Bar= 50lm. (G)
HUVEC cultured under static conditions were treated with varying quantities of BMP4 for 72h. mRNA levels of HoxB9 and ID1 were quantified by qRT-
PCR. N=6 experiments. (H) HUVEC were transfected with siRNA targeting BMP4 or with scrambled control sequences and then exposed for 72 h to low
WSS. mRNA levels of BMP4, HoxB9, and ID1 were quantified by qRT-PCR. N=4 experiments. (I) HUVEC cultured under static conditions were trans-
fected with siRNA targeting HoxB9 or with scrambled control sequences, and were treated with or without BMP4. mRNA levels of inflammatory molecules
and HoxB9 were quantified by qRT-PCR. N=6 independent experiments. (A–I) *P<0.05, **P<0.01, ***P<0.001 using a paired two-tailed t-test (A and I),
unpaired two-tailed t-test (D, E, andH), and one-way ANOVA (C and G).
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HoxB9, HoxD8, and HoxD9 in VSMCs was reduced in the aortic arch
compared to the thoracic aorta,26 whereas the expression of these Hox
genes in EC was enhanced at the inner curvature of the aortic arch.
Trigueros-Motos et al.26 suggested that regional differences in Hox gene
expression in VSMCs may reflects the divergent embryological origins of
VSMC at these sites which arise from neuroectoderm (aortic arch) and
paraxial mesoderm (thoracic aorta). By contrast, EC originate from para-
xial mesoderm throughout the aorta and it is therefore likely that regional
differences in Hox gene patterns are generated by environmental factors
such as local shear stress conditions. The observation that Hox genes are
co-expressed in atheroprone EC and atheroprotected VSMCs has implica-
tions for therapeutic targeting of these molecules which should be directed
specifically to the endothelial pool, e.g. using siRNA-nanoparticles.34
Hox genes influence angiogenesis by controlling the expression of integ-
rins, MMPs, ephrins, and other molecules,35 however, their functional sig-
nificance in adult EC is largely unknown. Here we used gene silencing to
study the potential role of Hox genes in regulating inflammation, prolifera-
tion, and apoptosis in EC exposed to low WSS. Our study revealed that
HoxB4, HoxB7, and HoxB9 were positive regulators of EC proliferation,
and that HoxB9, HoxD8, and HoxD9 had a pro-inflammatory function.
EC apoptosis was positively regulated by HoxB4. We conclude that Hox
genes regulate several pathophysiological functions in disease prone
regions of arteries. Most of the Hox genes that we studied had distinct
functional profiles with differing effects on inflammation, proliferation, and
apoptosis (Figure 6). Therefore, we propose that the expression pattern of
multiple Hox genes acts as a code that controls the fate of EC by inducing
activation, proliferation, or apoptosis. Further work is required to under-
stand the mechanisms that EC use to decode Hox gene expression pro-
files and convert this information into physiological responses.
4.2 A BMP4-HoxB9-TNF pathway primes
inflammation at disease-prone sites
We focused our studies on HoxB9 because inhibiting this Hox gene
could be particularly effective in treating atherosclerosis since it drives
two distinct pathophysiological functions, inflammation and proliferation.
Previous studies revealed that HOXB9 is essential for specification of
the thoracic skeleton27 and forelimbs.36 Here we demonstrate that in
addition to its roles in the patterning of organs during development,
HoxB9 also plays a role in the patterning of arterial inflammation. We in-
vestigated the mechanism and observed by qRT-PCR array that HoxB9
regulated the expression of multiple inflammatory molecules including
cytokines and other mediators (e.g. TNF, CD40), receptors (e.g. TNFR1,
TLRs), and signalling molecules and transcription factors (e.g. NF-jB,
TRAFs, IRAKs). Interestingly, Passerini et al.6 found that lowWSS primes
EC for enhanced inflammation by increasing the expression of multiple
cytokines, receptors, and signalling molecules belonging to several differ-
ent pathways. Here we provide a mechanism for inflammatory priming
at the low WSS site by demonstrating that HoxB9 is a high-level regula-
tor of the expression of multiple inflammatory components.We focused
our validation studies on the TNF-TNFR1 pathway and confirmed that it
is up-regulated by HoxB9 and required for NF-jB activation by low
WSS. Further work should now be carried out to determine the role of
HoxB9 in regulating other inflammatory pathways including the IL-1/
TLR35 pathway in atherosclerosis.
We next investigated the potential role of BMP4 in regulating HoxB9
expression because these molecules are coupled in developmental sys-
tems.32 Using cultured EC and murine models we demonstrated that
BMP4 is induced by lowWSS and that it is a positive regulator of HoxB9
and downstream inflammatory activation. Moreover, the expression of
BMP4, HoxB9, and TNFR1 at disease prone sites was increased under
hypercholesterolaemic conditions. These data are consistent with previ-
ous observations that BMP4 is a driver of inflammation and atherosclero-
sis at low WSS sites.14–16 Interestingly, Sorescu et al.16 previously found
that BMP4 enhances NOX1-dependent production of reactive oxygen
species (ROS) which are known to enhance NF-jB activation in re-
sponse to TNF.We propose therefore that BMP4 promotes vascular in-
flammation by activating two parallel pathways that act synergistically to
activate NF-jB; HoxB9-TNF-TNFR1 signalling; and NOX1-dependent
production of ROS. This concept is consistent with a well-recognized
role for TNF and ROS in arterial inflammation37 and it positions the
BMP4-HOXB9 pathway as a key upstream regulator. In addition to its
role in atherosclerosis, BMP signalling is involved in the pathogenesis of
other vascular diseases including pulmonary arterial hypertension38 and
hereditary haemorrhagic telangiectasia.39 Therefore, further studies
should now be carried out to determine the potential role of the BMP-
HoxB9-TNF axis in other vascular diseases.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
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Translational perspective
Here we report that BMP4-HoxB9-TNF signalling is activated at disease-prone regions of arteries and that it promotes endothelial cell turnover and
inflammation which are important initiators of atherosclerosis. The corollary is that components of this pathway that could be targeted therapeuti-
cally to prevent or treat atherosclerosis. Future studies should therefore determine whether inhibition of endothelial BMP4 or HoxB9, for example,
using siRNA nanoparticles, can reduce atherosclerosis. Moreover, BMP inhibitors are currently under development for the treatment of cancer, anae-
mia, and bone overgrowth and could be repurposed to treat atherosclerosis.
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